Y-90 Radioembolization · Los Angeles

Target selected liver tumors from the inside.

Internal radiation, planned around your liver and cancer care.

EVSLA reviews your diagnosis, imaging, liver function, prior treatment, and oncology plan to determine whether Y-90 may belong in your care.

Request a Y-90 Evaluation See If Y-90 May Fit

Y-90 is for selected patients and tumors. An evaluation does not guarantee candidacy, response, or a specific treatment outcome.

  • Liver directed
  • Image guided
  • Care coordinated
Y-90 liver-directed treatment planning
Before treatmentMapping shows where the microspheres may travel.Arterial anatomy and simulated particle flow help determine whether treatment can be delivered safely.
Part of the cancer planY-90 is considered alongside oncology, surgery, transplant, ablation, and other options.
Targeted inside the liver

Microspheres travel through selected liver arteries.

Planned with mapping

Anatomy and particle flow are evaluated first.

Coordinated cancer care

Treatment should support the broader oncology plan.

Could Y-90 fit your plan?

The answer depends on more than the scan. A specialist weighs the tumor, the liver, and the full cancer-care strategy before recommending treatment.

The diagnosis and treatment goal are clear

Y-90 may be discussed for selected primary liver cancers or cancer that has spread to the liver.

The tumor can be reached through selected liver arteries

Number, size, location, distribution, and arterial anatomy all shape what is technically possible.

Liver function can support the plan

Blood tests, cirrhosis, prior liver treatment, and how much healthy liver would be exposed matter.

Y-90 supports the broader cancer strategy

The team considers disease outside the liver, other treatment options, timing, health, and your goals.

How Y-90 treats from inside the liver

The procedure delivers microscopic beads containing yttrium-90 through the arteries that feed selected tumors. The radiation acts over a short distance around each microsphere.

1

Map the blood supply

Angiography and a simulation study show the liver’s arterial anatomy and help estimate where treatment particles may travel.

2

Guide a microcatheter

Using live X-ray imaging, the specialist advances a thin catheter into the selected artery supplying the treatment area.

3

Deliver internal radiation

Y-90 microspheres flow into the selected tumor territory and release radiation locally while treatment is planned to limit exposure elsewhere.

Y-90 treats a selected area of the liver—not cancer everywhere in the body. It is not the same as external-beam radiation, systemic chemotherapy, or TACE, and those treatments may still be part of the plan.

Two planned steps. One coordinated strategy.

Y-90 usually begins with a planning procedure, followed by treatment. Some patients need more than one treatment session, and timing varies.

01

Consultation and mapping

The team reviews imaging and labs, maps the arteries, and performs a simulation to help plan the treatment area and dose.

02

Image-guided treatment

If mapping supports treatment, the physician returns to the selected artery and delivers the prescribed Y-90 microspheres.

03

Recovery and response imaging

Follow-up covers symptoms, liver tests, individualized radiation-safety instructions, and imaging to assess the treated area.

Liver-directed care, led by specialists

Your specialist evaluates the imaging, arterial anatomy, liver function, and treatment goal before recommending Y-90 or another next step.

Board-certified specialists
Imaging-led treatment planning
Care coordinated with oncology
Three Los Angeles-area clinics
Harout Dermendjian, MD

Harout Dermendjian, MD

Board-Certified Vascular & Interventional Radiologist

Specialty training in oncology and other image-guided treatments, with a direct approach to complex decisions.

Meet Dr. Dermendjian →
Kartik Kansagra, MD

Kartik Kansagra, MD

Board-Certified Vascular & Interventional Radiologist

Clear communication and collaborative planning for complex vascular and minimally invasive care.

Meet Dr. Kansagra →
Sipan Mathevosian, MD

Sipan Mathevosian, MD

Board-Certified Interventional & Diagnostic Radiologist

Interventional oncology experience supporting careful planning for selected liver-directed treatments.

Meet Dr. Mathevosian →

You do not need to choose a physician before requesting care. EVSLA will route the case based on the clinical question, records, and availability.

Start your evaluation close to home

Choose the clinic most convenient for your evaluation. Procedure location and availability depend on the treatment and clinical need, and the scheduling team will confirm the appropriate site.

La Cañada Flintridge

1407 Foothill Boulevard
La Cañada Flintridge, CA 91011

Clinic details →

What patients ask about Y-90

Clear answers about treatment, mapping, recovery, and how Y-90 fits cancer care.

What is Y-90 radioembolization?

Y-90 is an image-guided internal radiation treatment. An interventional radiologist advances a thin catheter into selected liver arteries and delivers microscopic beads containing yttrium-90 to the tumor’s blood supply. The radiation acts over a short distance around the beads.

Who may be considered for Y-90?

Y-90 may be considered for selected primary liver cancers and selected cancers that have spread to the liver. Eligibility depends on the diagnosis, tumor number and location, liver function, arterial anatomy, overall disease burden, prior treatment, health, and goals of care.

Why is mapping needed before treatment?

Mapping defines the liver’s arterial anatomy and helps estimate where treatment particles may travel, including whether too much could reach the lungs or another organ. The result guides dose and catheter planning and may show that Y-90 is not appropriate.

Is Y-90 chemotherapy?

No. Y-90 uses internal radiation carried by microspheres. TACE delivers chemotherapy through liver arteries. Both are liver-directed treatments, but they work differently and are not interchangeable.

What are the risks and recovery after Y-90?

Fatigue, nausea, reduced appetite, fever, or abdominal discomfort can occur. Other risks include access-site bleeding or bruising, vessel injury, infection, contrast or medication reaction, liver injury, and rare non-target radiation injury involving the stomach, bowel, gallbladder, or lungs. Discharge timing, activity limits, and radiation-safety instructions are individualized.

Can Y-90 be combined with other cancer treatments?

Sometimes. Y-90 may be one part of a plan that also involves systemic therapy, surgery, transplant evaluation, ablation, external radiation, another embolization treatment, or observation. The sequence depends on the tumor, liver function, overall disease, and treatment goal.

We can help clarify the next step.

Share your current imaging, diagnosis, recent lab results, and oncology plan. EVSLA can review the full picture and explain whether Y-90—or another liver-directed option—makes sense to discuss.

Request a Y-90 EvaluationCall (818) 626–3710A request does not confirm candidacy, treatment, or insurance coverage.